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Abstract
Background: Gene transfer by electroporation (DNA electrotransfer) to muscle results in high level long term
transgenic expression, showing great promise for treatment of e.g. protein deficiency syndromes. However little
is known about the effects of DNA electrotransfer on muscle fibres. We have therefore investigated
transcriptional changes through gene expression profile analyses, morphological changes by histological analysis,
and physiological changes by force generation measurements. DNA electrotransfer was obtained using a
combination of a short high voltage pulse (HV, 1000 V/cm, 100 µs) followed by a long low voltage pulse (LV, 100
V/cm, 400 ms); a pulse combination optimised for efficient and safe gene transfer. Muscles were transfected with
green fluorescent protein (GFP) and excised at 4 hours, 48 hours or 3 weeks after treatment.
Results: Differentially expressed genes were investigated by microarray analysis, and descriptive statistics were
performed to evaluate the effects of 1) electroporation, 2) DNA injection, and 3) time after treatment. The
biological significance of the results was assessed by gene annotation and supervised cluster analysis.
Generally, electroporation caused down-regulation of structural proteins e.g. sarcospan and catalytic enzymes.
Injection of DNA induced down-regulation of intracellular transport proteins e.g. sentrin. The effects on muscle
fibres were transient as the expression profiles 3 weeks after treatment were closely related with the control
muscles. Most interestingly, no changes in the expression of proteins involved in inflammatory responses or
muscle regeneration was detected, indicating limited muscle damage and regeneration. Histological analysis
revealed structural changes with loss of cell integrity and striation pattern in some fibres after DNA+HV+LV
treatment, while HV+LV pulses alone showed preservation of cell integrity. No difference in the force generation
capacity was observed in the muscles 2 weeks after DNA electrotransfer.
Conclusion: The small and transient changes found in the gene expression profiles are of great importance, as
this demonstrates that DNA electrotransfer is safe with minor effects on the muscle host cells. These findings are
essential for introducing the DNA electrotransfer to muscle for clinical use. Indeed the HV+LV pulse combination
used has been optimised to ensure highly efficient and safe DNA electrotransfer.
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Background
In vivo gene transfer to skeletal muscle is a promising
strategy for treatment of muscular disorders and for sys-
temic delivery of therapeutic proteins. Transgene expres-
sion has been reported following intramuscular injection
of naked plasmid DNA [1], yet the clinical use is limited
due to low efficiency and large variation. By combining
intramuscular plasmid injection with local application of
electric pulses a 200-fold increase in transfection effi-
ciency with high reproducibility has been achieved in vivo
[2,3]. This proves that DNA electrotransfer can be an effi-
cient and feasible way of introducing genes into tissues.
DNA electrotransfer allows high production of systemic
delivered proteins e.g. erythropoietin [4,5] and cytokines
[6,7] with expression detected more than a year after treat-
ment in rodents [8,9].
The high level of gene expression in muscle after DNA
electrotransfer is a consequence of plasmid distribution,
membrane permeabilisation and plasmid electrophoresis
[10-12]. Recently efforts have been made to optimise the
electric pulses for gene transfer, resulting in a combina-
tion of a short high voltage (HV) pulse for membrane per-
meabilisation, followed by a long low voltage (LV) pulse
for electrophoretic transport of plasmid towards the cell
membrane. In skeletal muscle and skin the HV + LV pulse
combination has led to increased marker gene expression
[13].
DNA electrotransfer is moving rapidly towards clinical
use. In fact, electroporation in combination with chemo-
therapy (electrochemotherapy) has been used in the clinic
for several years now [14,15], showing encouraging
results for anti-tumour treatment with good tolerability
for the patients [16-18]. However the biological response
to electroporation and DNA electrotransfer in vivo
remains poorly defined. Rubenstrunk et al studied the
expression of stress related genes after DNA electrotrans-
fer, and found no significant variation between treated
and non-treated muscles [19]. Furthermore, studies have
shown that transient changes in force generation, muscu-
lar ion content and ATP levels were observed following
DNA electrotransfer [20]. Yet no thorough description of
the transcriptional changes caused by DNA electrotransfer
has been reported.
In this first comprehensive microarray analysis covering
the entire murine genome, we examine the transcriptional
changes underlying the muscular response to DNA elec-
trotransfer by evaluating the gene expression profiles of
mice tibialis cranialis muscles 4 hrs, 48 hrs and 3 weeks
after DNA electrotransfer using oligonucleotide microar-
rays and quantitative PCR (Q-PCR). Furthermore we per-
formed histology and physiological tests such as force
generation measurements and reflex and motor testing to
support our findings.
Results
The effect of DNA electrotransfer on gene expression 
profiles
For precise description of the transcriptional changes fol-
lowing DNA electrotransfer, total RNA was extracted and
pooled from 4 muscles excised 4 hrs, 48 hrs and 3 weeks
after treatment and gene expression profile analysis was
performed. Statistical analysis was employed by compar-
ing electroporated (EP) and non-EP groups, groups either
injected or not with plasmid, or groups at the different
time points.
Inferential statistics
By two-way ANOVA testing with a significance level of p =
0.001, 29 genes were found to be differentially expressed
between EP and non-EP groups, 38 genes were differen-
tially expressed in groups with or without intramuscular
plasmid injection, and 145 genes were differentially
expressed across time. To further filter the gene lists,
unpaired t-test with 50 permutations accepting a false dis-
covery rate (FDR) less than 5% and significance levels of
p = 0.05 were performed. In the EP vs. non-EP groups, the
unpaired t-test revealed that 27 of the 29 genes were sig-
nificantly differentially expressed (p = 0.05) of which 7
were up-regulated and 20 down-regulated. Unpaired t-test
among the groups injected with plasmid or not, revealed
that 36 genes were significantly differentially expressed (p
= 0.05) with 9 genes up-regulated and 27 down-regulated.
Unpaired t-test among genes differing across time resulted
in 130 genes with a false discovery rate of 8.5%, therefore
the significance level was changed to p ≤ 0.005, resulting
in 45 differentially expressed genes and a FDR of 0%.
Descriptive statistics and unsupervised clustering
Electroporated versus non-electroporated muscles
In an unsupervised cluster analysis, the EP groups clus-
tered significantly (p = 0.0006) together as depicted from
the sample correlation matrix plot in Fig. 1. No correla-
tion within the EP or non-EP clusters, as to whether the
groups had received plasmid injection or at which time
following treatment the muscles had been excised, was
established (additional file 1).
Performing gene ontology annotation (GO) on the cluster
analysis revealed that RNA encoding proteins assembling
the  cytoskeleton  e.g. microtubule-associated protein 7
(NM008635), cadherin-like 26 (BB748621) and sar-
cospan (BC021484) were down-regulated in the electro-
porated groups. Yet, 3 weeks after treatment the
expression of these genes in the DNA+HV+LV group had
returned to control levels (Table 1).BMC Molecular Biology 2007, 8:56 http://www.biomedcentral.com/1471-2199/8/56
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Furthermore expression of genes involved in the metabo-
lism  e.g. phosphoenolpuryvate carboxykinase
(BB024477) and dipeptidase (NM007876) were also
down-regulated following electroporation, indicating that
the general catabolism might be depressed. Ephrin
(D38146), which is involved in neural development and
cell-cell interaction among vascular endothelial cells were
found to be up-regulated in all EP groups.
Plasmid vs. no plasmid injection
The plasmid injected groups clustered significantly
together (p = 0.0006) in the sample correlation matrix
analysis with clear separation from the non-injected
groups (Fig. 2). Interestingly the LDA plot revealed that
within the plasmid injected groups, two apparent sub-
clusters of EP and non-EP groups were found. Likewise
among the non-injected groups, the EP groups formed a
distinct sub-cluster (additional file 2).
Table 1: Summary of transcriptional changes following gene 
transfer by electroporation
Gene Ontology EP DNA Time
Metabolism
phosphoenolpuryvate carboxykinase 2 ↓ 00
dipeptidase ↓ 00
protein phosphatase 6 0 ↓ 0
Cytoskeleton
sarcospan ↓ 00
microtubule-associated protein 7 ↓ 00
cadherin-like 26 ↓ 00
junction adhesion molecule 4 ↓ 00
Transcriptional regulation
Ephrin ↑ 00
Forkhead box P1 ↓ 00
F-box and leucine-rich repeat protein ↓ 00
ring finger protein 184 ↓ 00
splicing factor (SRp75) 0 0 ↑
Transducer of ERBB2 0 0 ↓
eukaryotic translation initiation factor 0 0 ↓
host cell factor C1 0 0 ↓
CCR4-NOT transcription complex 0 0 ↓
cytoplasmic polyadenylation element 0 0 0
MAPKK3 0 ↓ 0
polymerase II 0 ↓ 0
Ca2+ regulation
Reticulocalbin 2 0 ↓ 0
FK506 binding protein 1a 0 ↓ 0
Intracellular transport
ADP-ribosylation factor-like 6 and 10 0 ↓↓
ubiquitin-like 1 (sentrin) 0 ↓ 0
nuclear transport factor 2 0 ↓ 0
Membrane transport
Chloride channel Ka 0 0 ↑
Kruppel-like factor 15 0 0 ↓
K+ voltage gated channel, Shab related 0 0 ↓
Solute carrier family 6 0 0 ↓
ATP-binding cassette (ABC1) 0 0 ↓
Sample correlation matrix and hierarchical cluster analysis of  gene expression profiles after electroporation Figure 1
Sample correlation matrix and hierarchical cluster 
analysis of gene expression profiles after electropora-
tion. A sample correlation matrix (upper panel) between 
groups, which had been electroporated or not, was built on 
the basis of the original two-way hierarchical unsupervised 
clustering. Red indicates high correlation and blue represents 
less correlation. The original hierarchical unsupervised clus-
tering (lower panel) was performed with a distance measure 
of 1 – Pearson correlation coefficient and centroid linkage 
with a P-value threshold of 0.05 for significant sample clus-
ters and significant gene clusters. The columns indicate the 
treatment condition and the rows indicate the individual 
genes, listed with their Genbank number. Increases and 
decreases in mRNA expression levels are represented by 
shades of red and blue.BMC Molecular Biology 2007, 8:56 http://www.biomedcentral.com/1471-2199/8/56
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GO annotation showed that the expression of genes
involved in intracellular trafficking e.g. sentrin (ubiquitin-
like 1, NM016682), nuclear transport factor 2
(AA920031) and ADP-ribosylation factor-like 10C
(NM026011) were down-regulated in the plasmid
injected groups. In addition polymerase II (BC004810)
was also down-regulated in plasmid injected groups, indi-
cating the transcription also was depressed.
Furthermore the ER Ca2+ binding protein reticulocalbin
(NM011992) and Ca2+ release modulator FK506 binding
protein (AF483488) were both down-regulated following
plasmid injection, which might be important for control-
ling the Ca2+  homeostasis. Indeed we have previously
shown that DNA injection especially in combination with
electroporation affects the intracellular level of Ca2+
(manuscript in preparation).
Time
Groups within each of the 4 time points clustered signifi-
cantly together (Fig. 3) regardless of the treatment. The
LDA plot revealed that groups from 4 and 48 hrs clustered
closely together, while the control and 3 weeks groups
formed individual clusters (additional file 3).
At 4 hrs the chloride channel Ka (C76734) is up-regulated
in all groups compared to all other time point. At this ini-
tial time point after treatment and membrane permeabili-
sation, the ion homeostasis across the membrane might still
be disturbed, stimulating the expression of the Cl-chan-
nel. At 48 hrs and in the EGT-treated group at 4 hrs, the
transducer of ERBB2 (AV174616), was up-regulated. Up-
regulation of this inhibitor of proliferation might indicate
disturbances in the muscles, which limit the proliferation
potential transiently.
Compared to the control groups, the Cl- channel activator
Kruppel-like factor 15 (BC013486) and the K+ voltage-
gated channel (NM011862) were down-regulated at 4 hrs,
48 hrs and 3 weeks, indicating the ion homeostasis might be
disturbed longer than the initial phase. Similarly the sol-
ute carrier family 6 protein (bg069516), which transports
creatine into the muscle cells and is essential for energy
consumption, was also down-regulated at all time points
compared to the control groups.
At 4 and 48 hrs the transcription activator host cell factor C1
(bg864583), the regulator of polymerase II CCR4-not
transcription complex (BM202561) and the polyadenyla-
tion element binding protein (NM026252) were down-
regulated compared to the control and 3 weeks groups;
indicating that the protein synthesis apparatus might be
negatively affected within the first 48 hrs after treatment.
Sample correlation matrix and hierarchical cluster analysis of  gene expression profiles after DNA injection Figure 2
Sample correlation matrix and hierarchical cluster 
analysis of gene expression profiles after DNA injec-
tion. A sample correlation matrix (upper panel) between 
DNA injected or non-injected groups was built on the origi-
nal two-way hierarchical unsupervised clustering. Red indi-
cates high correlation and blue represents little correlation. 
In the original hierarchical unsupervised clustering (lower 
panel) the columns indicate the treatment condition and the 
rows indicate the individual genes, listed with their Genbank 
number. Increases and decreases in mRNA expression levels 
are represented by shades of red and blue.BMC Molecular Biology 2007, 8:56 http://www.biomedcentral.com/1471-2199/8/56
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Q-PCR validation of differentially expressed genes
The gene expression levels were validated by Q-PCR for 11
selected genes (Table 2). These measurements confirmed
the level of mRNA determined by microarray analysis. For
example transducer of ERBB2 (AV174616) was in the
array analysis found to be up-regulated at 48 hours after
all treatments, indeed Q-PCR also showed that the trans-
ducer of ERBB2 was up-regulated at 48 hours e.g. in the
case of DNA+HV+LV treatment by 6-fold. Similarly the
expression of the solute carrier family 6 (BG069516),
responsible for creatine transport, was verified by Q-PCR
to be down-regulated at 4 and 48 hours.
Histological changes in tibialis cranialis muscles after DNA 
electrotransfer
Preparations of muscles slides were stained with HE and
examined for morphological changes like integrity of
fibres, central nuclei and fainting striation pattern. Fur-
thermore, CD4 and CD8 staining were performed on par-
allel slides to verify infiltration of mononuclear cells. At 4
hrs, no histological changes were observed for the control,
DNA injected and electroporated muscles (Fig. 4). Contra-
rily after DNA+HV+LV treatment, loss of fibre structure
and fainting striation pattern was observed in 15% of the
muscle. After 48 hrs, no changes were observed in the con-
trol and DNA injected muscles, while the electroporated
muscles exhibited fainting striation pattern in a few mus-
cle fibres. In the DNA+HV+LV treated muscles, structural
changes with loss of cell integrity and striation pattern
were observed in 15% of the fibres, in addition limited
intra-fiber infiltration of mononuclear cells was also
observed. Three weeks after treatment, the DNA+HV+LV
treated muscles had around 5% of the fibres containing
central nuclei, indicating regenerating myocytes. In the
electroporated muscles single cells with central nuclei
were also detectable, while the control and DNA injected
muscles showed no signs of histological changes.
No loss in muscle performance after DNA electrotransfer
The reflex and motor function of mice were tested by
assessing the running and seizing patterns. Thus, mice
were allowed to run on the top of the cage, their tails were
gently manually lifted, and it was observed whether they
could grasp the bars with normal force. Similarly, sponta-
neous motoric movement was observed in the cage. Fig. 5
depicts the average score, short duration films of the test
results can be found in additional file 4, 5, 6, 7, 8, 9, 10,
11, 12, 13, 14, 15, 16, 17, 18, 19. At 4 hours the mice had
not fully awoken from the anaesthesia and could there-
fore not be tested. At 48 hours no effects were observed in
the control and DNA injected mice, while slight impair-
ments were observed in a couple of the electroporated and
DNA+HV+LV treated mice. From 5 days after treatment
no functional impairments in the seizing and running
patterns were observed in any of the mice.
Sample correlation matrix and hierarchical cluster analysis of  gene expression profiles at different time points Figure 3
Sample correlation matrix and hierarchical cluster 
analysis of gene expression profiles at different time 
points. A sample correlation matrix (upper panel) was built 
from groups evaluated at different time points. Red indicates 
high correlation and blue represents little correlation. In the 
original hierarchical unsupervised clustering (lower panel) 
the columns indicate the treatment condition with the desig-
nation 1 = 4 hours, 2 = 48 hours, 3 = 3 weeks and C = con-
trol. The rows indicate the individual genes, listed with their 
Genbank number. Increases and decreases in mRNA expres-
sion levels are represented by shades of red and blue.BMC Molecular Biology 2007, 8:56 http://www.biomedcentral.com/1471-2199/8/56
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The effects of DNA electrotransfer on the force generating
capacity were tested in rat EDL muscles 2 weeks after treat-
ment and depicted in Fig. 6. Rat EDL muscles were chosen
for this measurements as mice TA cannot be used in our
set-up. The force generating capacity in the DNA electro-
transferred and electroporated muscles did not differ sig-
nificantly from the control muscles.
Discussion
DNA electrotransfer to skeletal muscle is highly efficient
and holds great promise for future treatment of monoge-
netic disorders, protein deficiency syndromes, cancers,
etc. For electric pulsing of muscle in vivo trains of long
low field strength pulses have typically been employed
[2,21]. However studies have shown that the electric
pulse-mediated gene transfer might consist of two compo-
nents; a component, which permeabilises the membrane,
and an electrophoretic component, which can facilitate
the transport of plasmid DNA across the membrane
[10,12]. Using combination pulses, a short high voltage
permeabilising pulse followed by a long low voltage elec-
trophoretic pulse, less intense pulsing parameters are
needed for obtaining the same expression levels, which
reduces the discomfort from the pulsing regiment. Indeed
in this study we confirm these observations as little
changes in the gene expression profiles are observed.
Moreover we find less histological changes than previ-
ously described after DNA electrotransfer with trains of
Reflex and motor function in mice after DNA electrotransfer  in vivo Figure 5
Reflex and motor function in mice after DNA elec-
trotransfer in vivo. Mice were tested for reflex and motor 
function according to a system, where 0 = normal function, 1 
= function affected and 2 = function gravely affected. The 
total score (reflex + motor) is depicted for the following 
time points pre-treatment, 48 hours, 4 days and 1 week and 
(n = 12).
Table 2: Validation of differential expressed genes after DNA electrotransfer
Inj. alone DNA alone HV + LV DNA + HV + LV
4  H4 8  H4  H4 8  H 3  W4  H4 8  H3  W4  H4 8  H3  W
Trans ERBB2 1,00 4,52 9,35 4,66 6,10 5,61 4,17 5,25 3,34 1,02 6,30 -1,83
FK506 binding pt. 1,00 0,68 -0,44 2,73 0,56 0,94 0,75 0,63 0,52 1,17 0,53 0,86
Solute carrier family 1,00 -0,79 -1,07 0,11 -0,34 0,25 -0,60 -0,66 0,05 0,59 -0,56 0,83
Reticulocalbin 2 1,00 0,89 0,24 3,19 0,55 0,91 0,95 0,82 0,62 1,19 0,53 1,00
Ceramide kinase 1,00 0,41 -0,85 2,97 0,73 1,00 0,59 0,53 0,45 1,02 0,81 1,27
Phosphoenol pur. 1,00 -1,99 -4,06 -0,42 -3,39 0,36 -2,29 -2,58 -1,59 -1,14 -3,39 0,02
Nuc. transport factor 1,00 1,16 0,72 3,21 0,57 0,93 1,05 1,00 0,68 1,24 0,52 1,03
Polymerase II 1,00 1,31 0,55 3,85 0,61 1,10 1,25 1,15 0,85 1,39 0,68 1,15
Sarcospan 1,00 1,14 -0,55 4,93 -0,17 0,88 0,65 0,40 0,46 3,26 0,55 1,65
Ubiquitin-like 1,00 0,00 -0,08 2,79 0,06 0,89 -0,09 -0,19 0,34 0,92 0,00 0,82
Ca-channel 1,00 0,21 0,00 3,39 0,21 1,14 0,48 -0,13 0,69 1,24 0,12 0,79
Eleven genes were selected for Q-PCR validation of their expression level. The genes were normalised to β-microglobulin and down and up-
regulation in expression compared to the control muscles were determined.
Histological changes after DNA electrotransfer to TC mus- cles Figure 4
Histological changes after DNA electrotransfer to 
TC muscles. Muscles were excised 4 hours, 48 hours and 3 
weeks after DNA electrotransfer, and fixed and stained with 
hematoxylin and peroxidase-conjugated CD4 antibodies. 
Representative pictures from 4 slides from the different con-
ditions are depicted.
Control DNA alone HV + LV DNA + HV + LV
4
H
3
w
e
e
k
s
4
8
HBMC Molecular Biology 2007, 8:56 http://www.biomedcentral.com/1471-2199/8/56
Page 7 of 12
(page number not for citation purposes)
long, low field strength pulses [22,23]. In addition we find
no reductions in muscle performance 2 weeks after treat-
ment, indicating that no major muscle regeneration is
required after DNA electrotransfer.
Array analysis, clustering and time aspect
Due to the expenses of the study, the replica number was
low in this study, however this was accommodated by
designing our statistical analysis as a multiple factor anal-
ysis. During the inferential statistics we performed an
ANOVA test, which gives an efficient and comprehensive
evaluation despite the low replicate number in this set-up
[24]. Moreover, permutation test and unpaired T-tests
were performed using stringent level of significance to
correctly identify genes that were differentially expressed.
Furthermore extensive descriptive statistics were per-
formed, which supported the findings of differentially
expressed genes. Unsupervised cluster analyses showed
clear separations between EP and non-EP muscles and
DNA injected or non-injected muscles, indicating that the
differentially transcribed genes in these clusters were
highly characteristic for the given treatment. Indeed some
of the changes we observed were in line with previous
reported changes following DNA electrotransfer to cells.
Not surprisingly the gene expression profiles at 4 and 48
hrs were relatively comparable, while the gene expression
profiles after 3 weeks were more similar to the control
muscles. This indicates that the observed changes after
DNA electrotransfer are transient, followed by a return to
the naïve state of the muscle. The most striking point
about the expression profiles is that no genes involved in
stress, immune responses, cell death or muscle regenera-
tion were found to be differentially expressed, demon-
strating that EGT is non-toxic. Indeed guided supervised
cluster analysis looking at cell homeostasis, ion homeos-
tasis and immune response ontologies showed no signifi-
cant changes in the gene expression profiles.
DNA electrotransfer-induced transcriptional changes
Based on previous in vitro studies certain effects of electro-
poration and plasmid injection would have been
expected. Electroporation of cells is known to cause
cytoskeleton rearrangements and electro-conformational
changes of ion channels, while DNA injection is associ-
ated in cytotoxic effects on the cells.
Changes in cytoskeleton-associated proteins
During the application of an electric field across cells, elec-
tro-compressive forces exert pressure on the membrane
leading to elongation of cells. During this elongation
phase the pressure on the membrane enlarges, resulting in
the development of membrane destabilisations, which
allow for entry of plasmids [25,26]. Formation of micro-
villi and blebs associated with deformation of the
cytoskeleton has been observed immediately after pulsing
[27,28]. In fact, the same phenomenon is observed in
cyclic stretch-induced gene transfer, where cytoskeleton
rearrangements are involved in mediating the gene trans-
fer [29]. In this study we found down-regulation of
cytoskeleton proteins after electro-pulsing, corresponding
to the reported deformations of the cytoskeleton after
pulsing. Interestingly, studies have shown that muscle
contractile function returns to normal within 4 hours after
EGT with the HV+LV pulse combination (manuscript in
preparation), indicating that the cytoskeleton rearrange-
ments only have a minor effect on the muscle function.
Electro-conformational changes of ion channels
During electro-pulsing, voltage-dependent ion channels
are particularly sensitive to the external electric field due
to their intrinsic voltage sensors. High intensity electric
fields cause structural changes, also known as electro-con-
formational changes, which especially affect the moveable
charge particles in the channel [30,31]. Chen et al have
shown that the movement of charge particles in the
delayed rectifier K+ channels was reduced after applying
an external transmembrane potential of 400 mV [31,32].
This applied membrane potential is considerably larger
than the 150 – 200 mV required for lipid bilayer break-
down. At lower than 400 mV field intensities no current
changes demonstrating conformational changes were
observed [31]. In our study we found down-regulation of
Force recovery in rat EDL muscle after DNA electrotransfer  in vivo Figure 6
Force recovery in rat EDL muscle after DNA electro-
transfer in vivo. The right EDL muscle of rats was electro-
transferred with 5 µg pGFP-S65T (DNA+HV+LV) or only 
subjected to electric pulses (HV+LV). The left EDL muscle 
served as untreated control. Two weeks after DNA electro-
transfer the animals were sacrificed and the EDL muscles 
were excised and placed in a force displacement transducer. 
Force was measured using 90 Hz pulse trains with duration 
of 0.5 s. Force of the treated muscle was recorded and 
related to force in the contralateral control muscle. Mean 
values with bars denoting SD are given, n = 4 muscle sets. 
There were no significant difference between the treated and 
the control muscles.BMC Molecular Biology 2007, 8:56 http://www.biomedcentral.com/1471-2199/8/56
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the K+ voltage-gated channel. Although our applied elec-
tric field does not reach amplitude of 400 mV at the mem-
brane level, weaker field strengths might be sufficient to
induce electro-conformational changes of ion channels in
muscle fibres, as these cells are larger. This suggests that
electro-conformational changes might play a role in the
regulation of voltage-gated channels after DNA electro-
transfer in vivo.
Effects of plasmid injection
Intramuscular injection of plasmid can be associated with
toxicity in the target tissue [33,34]. Hartikka et al (2001)
observed that muscle damage after DNA electrotransfer
with super-coiled endotoxin-free plasmid was DNA
dependent. When introducing 50 µg of plasmid into the
quadriceps muscle, they observed lesions with necrotic
myofibres and infiltration of inflammatory cells. After
injection of vehicle and electric pulses delivery no such
lesions were observed. We have used a low concentration
of plasmid, which might explain why we observed little
infiltration at our histological evaluation and no effects
on the transcriptional level.
Intracellular plasmid DNA transport
Unexpectedly we found that proteins involved in intracel-
lular transport were down-regulated following DNA injec-
tion. After entry into muscle fibres plasmid DNA must be
transported to the nuclei for transcription, but as the cyto-
plasmic latticework is quite condense, it is unlikely that
this transport occur by simple diffusion [35]. In HeLa and
COS cells it has been shown that plasmid DNA has a lim-
ited half-life (1 – 2 hours) in the cytosol due to degrada-
tion by cytoplasmic nucleases [36,37], meaning that
efficient transport to the nucleus is required. In fact stud-
ies have shown that the cytoplasmic movement of DNA
towards the nucleus in cells is facilitated by the microtu-
bular network [38]. The down-regulated intracellular
transport proteins are not directly involved in these trans-
port pathways, but they belong to a group of proteins,
which might be a limiting factor in efficient gene transfer.
This could therefore be of importance for the transfection
efficacy.
Conclusion
DNA electrotransfer by HV+LV pulses demonstrates small
and transient adverse effects on the muscle. This is highly
important for introduction in the clinical setting, where
numerous applications of this technology are envisaged.
Examples of interesting pre-clinical experiments with gene
transfer to muscle tissue include correction of anaemia
[39-42] or β-thalassemia [43,44] by electrotransfer of
EPO. Furthermore DNA electrotransfer can also be used to
target the muscle itself, either for research purposes or for
correction of muscle anomalies e.g. muscular dystrophies.
In this regard, it is important that the gene transfer proce-
dure itself imposes minimal effects on the target tissue.
In conclusion DNA electrotransfer using the HV+LV pulse
combination is safe with only small changes in the expres-
sion of cytoskeletal and intracellular transport proteins,
while most importantly no detrimental changes in muscle
performance or gene expression profiles of proteins
involved in cell death, inflammation or muscle regenera-
tion was verifiable both shortly and long after treatment.
Histology did, however, revealed some cells with mor-
phological changes after 4 and 48 hrs and few cells con-
taining central nuclei after 3 weeks.
Methods
Animals
Six to eight weeks old female C57Black/C mice (average
weight 22 g, Taconic, Denmark) or 4 – 5 weeks old male
or female Wistar rats (own breed, University of Aarhus)
were kept under pathogen-free conditions at 22°C in a
14/10 hrs light/dark cycle with food and water ad libitum.
All animal experiments were conducted in accordance
with the recommendations of the European Convention
for the Protection of Vertebrate Animals used for Experi-
mentation and after permission from the Danish Animal
Welfare Committee.
Plasmid DNA and in vivo DNA electrotransfer
The plasmid phGFP-S65T, encoding the green fluorescent
protein (GFP), was obtained from Clontech (Palo Alto,
CA, USA). DNA preparations were performed using Qia-
filter Plasmid Maxiprep kits (Qiagen, Germany), and the
concentration and quality of the plasmid preparations
were controlled by spectrophotometry, accepting a 260/
280 ratio of 1.8–1.9 and by gel electrophoresis.
Five micrograms of plasmid was dissolved in 20 µl PBS
(Phosphate-buffered saline without MgCl2, the Hospital
Pharmacy at Herlev, Denmark), and the plasmid solution
was injected intramuscularly along the fibres into the tibi-
alis cranialis muscle of anaesthetised C57Bl/6 mice using
an insulin syringe. For rats, 5 µg/10 µl PBS were injected
into the EDL muscle. Plate electrodes with 4-mm gap were
fitted around the hind legs and an electric field was
applied using the Cliniporator™ (IGEA, Italy). The muscle
was pulsed with a combination of a high voltage pulse
(100 µsec, 1000 V/cm) followed by a long low voltage
pulse (400 ms, 100 V/cm) with 1 s lag between the pulses.
RNA extraction and gene expression analysis
Four hrs, 48 hrs and 3 weeks after treatment the mice were
euthanized and the muscles were removed and placed in
1 ml solution D (guandinium thiocyanat, sodium citrate,
sarcosyl and mercaptoethanol) on ice. Muscle extracts
were prepared by homogenising the muscles with a rotor-BMC Molecular Biology 2007, 8:56 http://www.biomedcentral.com/1471-2199/8/56
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stator homogeniser (S8N – 5G, IKA-werke, Germany),
and RNA were extracted using the Chomczynski and Sac-
chi method [45] and digested with DNase (Promega,
Ramcon, Denmark). The extracted RNA amount ranged
from 5 – 33 µg with a mean concentration of 14.3 +/- 7.9
µg.
Due to low yield of total RNA, mRNA were amplified
yielding antisense RNA (aRNA) using the MessageAMP II
aRNA kit (Ambion, Europe). Briefly, total RNA were
reverse transcribed into first strand cDNA using a T7
Oligo(dT) primer and M-MLV reverse transcriptase and
incubated at 42°C for 2 hrs. Second strand cDNA was syn-
thesized using DNA polymerase and purified on cDNA fil-
ter cartridge according to the manufacturers protocol. An
in vitro transcription (IVT) reaction was set up to generate
multiple copies of aRNA from the double stranded cDNA
through incubation at 37°C for 14 hrs.
Affymetrix microarray analyses were preformed at the
Affymetrix core facility at the Microarray Center at
National University Hospital. In short 5 µg aRNA was
used to synthesize double stranded cDNA using Super-
script®  Choice System (Invitrogen, Denmark) with an
oligo(dT) primer containing a T7 RNA polymerase pro-
moter (GenSet, Evry, France). The cDNA was used as tem-
plate for an IVT reaction to generate biotin-labelled
antisense cRNA (BioArray™ High Yield RNA Transcript
Labelling Kit; Enzo Diagnostics, Farmingdale, NY, USA).
After fragmentation at 94°C for 35 min in fragmentation
buffer (40 mM Tris, 30 mM MgOAc, 10 mM KOAc), the
labelled cRNA were hybridised for 16 hrs to Affymetrix
MOE 430 2.0 arrays (Affymetrix, Santa Clara, CA, USA).
The arrays were washed and stained with phycoerythrin
conjugated streptavidin using the Affymetrix Fluidics Sta-
tion® 400, and the arrays were scanned in the Affymetrix
GeneArray®  scanner to generate fluorescent images, as
described in the Affymetrix GeneChip protocol.
Microarray data analysis and statistics
The cel image files (Affymetrix) were imported, pre-proc-
essed and analysed in DNA-Chip Analyser 2006. The array
files were normalised using the non-linear invariant set
normalisation method, choosing array (DNA-EP-48 HRS)
as baseline. Normalisation curves were visually inspected
and none of the arrays were critical. In order to interpret
the probe signal, model-based gene expression indexes
(MBEI) [46] gene expression modelling was calculated
using the PM/MM (perfect match/miss match) method.
During the analysis array outliers were detected. None of
the arrays exceeded 1.4% of array outliers and the probe
presence call was between 36.6% and 50.3%. The experi-
ment conditions and replicate number were electroporation
(n = 13 with nEP+ = 7 and nEP- = 6), DNA injection (n = 13
with nDNA+ = 7 and nDNA- = 6) and time interval (n = 13
whereas nctrl = 3, ntime 4 hrs = 4, ntime 48 hrs = 3 and ntime 3 weeks
= 3)
Raw data from the experiment are available at the gene
Expression Omnibus database (GEO) in a MIAME com-
pliant format. They are submitted under the serial code
GSE6686, and under the following sample codes
GSM154212, GSM154215, GSM154216, GSM154218,
GSM154222, GSM154226, GSM154230, GSM154233,
GSM154234, GSM154235, GSM154236, GSM154237,
GSM154238.
Inferential statistics were adapted to the data by two-way
ANOVA testing with a significance level of p ≤ 0.001,
which have been described to give high power in multiple
factor experiments [24]. To further filter the gene lists,
unpaired t-test with 50 permutations accepting a false dis-
covery rate (FDR) less than 5% and significant level of p =
0.05 were performed. An unpaired t-test among genes dif-
fering across time resulted in 130 genes with a false dis-
covery rate of 8.5%, therefore the significance level was
changed to p ≤ 0.005, with a result of 45 differentially
expressed genes and a FDR of 0%.
Descriptive statistics were applied to the significant data to
obtain biologically meaningful patterns.
Unsupervised two-way hierarchical clustering was per-
formed with a distance measure of 1 – Pearson correlation
coefficient and centroid linkage with a P-value threshold
of 0.05 for significant sample clusters and significant gene
clusters [46].
A sample correlation matrix (SCM) was built on the basis
of the original hierarchical unsupervised clustering, pro-
viding valuable information of how efficiently the clusters
correlated. Supervised analyses were performed by apply-
ing specific issue algorithms of interest (downloaded from
NetAffx™ Analysis Center). The issues of interest were cell
homeostasis, ion homeostasis, ion channel activity and
immune responses. To obtain significant data the data
was filtered by an unpaired t-test with a significance level
of p ≤ 0.05 and variation across samples between 0.50 <
Standard deviation/mean < 1000.00. No FDR criterion
was applied because we wanted to see a possible existing
pattern. Furthermore to find a linear combination of
explanatory variables and coefficient estimates within the
three groups of interest (EP, Plasmid, time) the difference
between the distributions of linear discriminate scores
(LDA-plot) for each group was maximized.
Finally the supervised analysis tool gene ontology (GO)
was applied to the data. Data from the two-way hierarchi-
cal clustering was uploaded to two software programs
EASE and NetAffx™ Analysis Center, which have the abili-BMC Molecular Biology 2007, 8:56 http://www.biomedcentral.com/1471-2199/8/56
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ties to calculate the GO similarity. The comparison criteri-
ons within the groups were set to the highest similarity
within the genes of same gene category.
Quantitative PCR
Two-step real-time reverse transcription polymerase chain
reaction (RT-PCR) was performed to validate samples of
differentially regulated genes in the electrotransferred
muscles as determined by interferential statistic analysis.
The aRNA prepared for the array hybridisation was reverse
transcribed using random p(dN)6 primers (Roche, Ger-
many) and AMV reverse transcriptase (Roche, Germany).
Eleven selected genes were amplified from the cDNA
using the Brilliant SYBR Green Q-PCR kit (Stratagene, AH
Diagnostics, Denmark). The primers were designed using
Primer3 and PCR and detection was performed by Q-PCR
(MX3000P, Stratagene, AH Diagnostics, Denmark). The
RNA levels were normalised to β-microglobulin and
down and up-regulation in expression compared to the
control muscles were determined.
Evaluation of macroscopic and histological changes and 
GFP expression in tibialis cranialis muscles
Respectively 4 hrs, 48 hrs and 3 weeks after treatment the
mice were euthanized and whole tibialis cranialis muscles
were carefully isolated and evaluated for macroscopic
changes. The isolated muscles were either evaluated for
GFP expression by fluorescence stereo microscopy (Nikon
SMZ1500, Japan) in blinded and randomised order or
fixed in 1 ml formalin buffer and imbedded in paraffin
blocks following standard procedures. Sections 3 – 5 µm
thick were stained with hematoxylin and eosin (Mayer-
Sour) or with alkaline phosphatase-conjugated CD4 anti-
bodies followed by counterstaining with Mayer's hema-
toxylin.
Test of function
The treated animals were tested for their ability to seize a
grid by placing the animal on the grid and lifting the hind
part by the tail. Animals with normal muscle function
were given the score 0, while animals with affected func-
tion were rewarded 1 and those, who did not seize the grid
at all were scored 2. For running the animals were placed
alone in an empty cage. Normal running were given the
score 0, while animals with a limp were given 1 and ani-
mals that did not support on the leg were rewarded 2. A
combined score from the two tests were then calculated.
Measurement of force
Force was measured as previously described in detail by
Clausen & Everts [47]. In brief, isolated EDL muscles were
mounted vertically with their tendons intact on a force
displacement transducer (Grass FT03, W. Warwick, RI,
USA) for isometric contractions in thermostatically con-
trolled (30°C) chambers containing standard Krebs-
Ringer bicarbonate buffer (pH 7.3) with (in mM): 122.1
NaCl, 25.1 NaHCO3, 2.8 KCl, 1.2 KH2PO4, 1.2 MgSO4,
1.3 CaCl2, and 5 D-glucose and gassed continuously with
a mixture of 95% O2 and 5% CO2. Direct electrical stimu-
lation was delivered via platinum electrodes on either side
of the mid-portion of the muscle. Muscle length was
adjusted to optimal length during repeated stimulation
with single pulses. Finally force was checked using short
tetanic contractions induced by supramaximal 1 ms
pulses of 10 V at 90 Hz for 0.5 sec.
Abbreviations
EGT – DNA electrotransfer, EP – electroporation, GO –
gene ontology, HV – high voltage, LV – low voltage.
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